Navigation Links
Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients

TSX: CTI OTCBB: CHKT

VANCOUVER, March 12, 2007 /PRNewswire-FirstCall/ - Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") , a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced positive preliminary data and the successful completion of the dose-escalation portion of its Phase Ib/II clinical trial for CTCE-9908, the Company's anti-cancer drug candidate. No dose limiting toxicities were observed in any of the cancer patients and two out of three patients with ovarian cancer responded positively and exhibited stable disease.

Chemokine Therapeutics will now proceed with the remaining portion of the clinical trial in which up to twenty additional patients will be treated at 5mg/kg/day. The Company expects to enroll the remainder of the patients and complete the current trial by the end of Q3 2007. The Company has also accelerated its efforts to initiate a large Phase II program in the U.S. by the end of 2007. Accordingly, a pre-IND meeting has been scheduled with the FDA to discuss the Company's future clinical trial program.

"We are very pleased that no dose-limiting toxicities were observed in the first part of the trial and encouraged by the positive outcome in the small group of ovarian cancer patients," said Dr. Hassan Salari, Chemokine Therapeutics President and CEO. "It is quite remarkable to see clinical evidence of efficacy considering these patients have exhausted every therapeutic avenue. We are now looking to rapidly expand the number of patients in Phase II clinical trials of CTCE-9908 to examine the potential broader applicability of this novel oncology drug in the treatment of cancer patients."

The primary purpose of this study is dose-selection and evaluation of safety and tolerability of CTCE-9908. CTCE-9908 is administered via a 30-minute infusion on weekdays over a treatment p
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014   Los Angeles orthodontics ... AcceleDent® Aura to patients who want to make their ... available at the OrthoSpaceship, all patients have a powerful ... This system can be used by most patients with ... of progress by using the AcceleDent® Aura system for ...
(Date:8/27/2014)... By now, if you haven,t heard about the ... planet. The awareness campaign has brought this devastating disease to ... over $88.5 Million (and counting) for ALS. Every day, more ... starting to as well. One such company, Acorn ... who actually works with ALS sufferers and helps to provide ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
Breaking Medicine Technology:Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... Del., Dec. 22, 2010 AstraZeneca ... notified Abbott that it will discontinue the development of CERTRIAD™ ... the treatment of mixed dyslipidemia. This means the co-development and ...   A Complete Response Letter (CRL) for the ...
... Dec. 22, 2010 The U.S. Food and Drug Administration ... anal cancer and associated precancerous lesions due to human ... people ages 9 through 26 years. (Logo: ... approved for the same age population for the prevention ...
Cached Medicine Technology:FDA: Gardasil Approved to Prevent Anal Cancer 2FDA: Gardasil Approved to Prevent Anal Cancer 3
(Date:8/27/2014)... locations will each receive $100,000 in funding to launch ... follow-up care for patients served by community health centers. ... Cancer Roundtable and is part of the group,s effort ... 50 and over receiving regular screening for colorectal cancer ... competitive process are: Port Royal, South Carolina; New Haven, ...
(Date:8/27/2014)... 27, 2014 Driven by the expanded ... expected to grow steadily during the next few years, ... 1.381 billion meters by end-2017. Tightness is an essential ... one of the most-used parts in an automobile. As ... at 995 million meters, up just under 15% y-o-y. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Georgia ... has received a two-year, $600,000 grant from the ... Resources and Services Administration to support implementation of ... services for children and youth with autism spectrum ... worked with an Autism Advisory Council composed of ...
(Date:8/27/2014)... last things a parent wants to deal with, but ... a week old. , Skin that turns yellow can ... and isn,t adequately eliminating the chemical bilirubin. But that ... left untreated can harm a baby. , University of ... that checks for jaundice in newborns and can deliver ...
(Date:8/27/2014)... 2014) -- Extremely low levels of the compound in ... halt the progression of Alzheimer,s disease, a recent study ... , Findings from the experiments, using a cellular model ... Journal of Alzheimer,s Disease . , Researchers from ... low doses of THC reduce the production of amyloid ...
Breaking Medicine News(10 mins):Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3Health News:Marijuana compound may offer treatment for Alzheimer's disease 2
... managed by a specialty pharmacy program were more compliant ... hospitalized for their disease than those who were not ... study completed by HealthCore, Inc. , HealthCore researcher Jingbo ... of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting ...
... against Chronic Migraines from Post-Traumatic Stress DisorderNEW YORK, May ... is making its new migraine treatment available free to ... According to published reports, alarming numbers of service men ... are suffering from migraines related to post-traumatic stress disorder ...
... WASHINGTON, May 20 The Council for American ... appointment and confirmation of Margaret Hamburg, M.D., to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )"Commissioner Hamburg takes ... States faces unprecedented challenges in public health, and ...
... an economic environment in which all Americans are trying ... were prevented from filling critical prescriptions due to healthcare ... a solution. Medtipster ( www.medtipster.com ) has ... search engine and generic prescription drug price comparator. Now ...
... care for a loved can be a very complicated issue ... begin, let alone the right questions to ask when they ... consider it.The Heinz Family Philanthropies is adding a new series ... " 10 QUESTIONS TO ANSWER... "About Long-term Care. This ...
... the 80th anniversary of The Children,s Center of Wayne ... a Power of Possibilities Breakfast is being held on ... http://www.newscom.com/cgi-bin/prnh/20090423/CCWCLOGO ) Embarking on its ... of founder Senator James Couzens. His intention was ...
Cached Medicine News:Health News:MS patients more compliant with medications when managed by specialty pharmacy 2Health News:Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers 2Health News:Council for American Medical Innovation Applauds the Confirmation of Margaret Hamburg, M.D., to Lead U.S. Food and Drug Administration 2Health News:Medtipster, a Search Engine With a National Database of Generic Drugs on Discount Programs That Allows Visitors to Search by Zip Code, by Lowest Price, is Now Out of Beta 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 3Health News:80th Anniversary Power of Possibilities Breakfast Honors the Children's Center of Wayne County 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: